Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=66221453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010001274(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filedfiledCritical
Publication of CL2010001274A1publicationCriticalpatent/CL2010001274A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona o una sal y el acido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico o una sal; kit farmacéutico; y uso en enfermedades de proliferación celular.Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone or a salt and the acid n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl ) ethyl) benzoyl) -l-glutamic acid or a salt; pharmaceutical kit; and use in cell proliferation diseases.
CL2010001274A2008-06-062010-11-19
Pharmaceutical combination comprising 3-z- [1- (4- (n - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -n-methyl-amino) anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone and n- [4- [2- (2-amino-4,7-dihydro-4-oxo-1h-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl) benzoyl acid ) -l-glutamic; pharmaceutical kit; and use in cell proliferation diseases
CL2010001274A1
(en)
3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE 4- (4-FLUORO-2-METHYL-1H-INDOL-5-ILOXI) -6-METOXI-7- (3- (PIRROLIDIN-1-IL) PROPOXI) QUINAZOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME , PREPARATION AND USE PROCESSES
SUBSTITUTED 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON AND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATES AND THEIR USE IN NEURODEEGENERATIVE DISEASES